Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C1522282 (
EMT
)
2,868
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The major cause of cancer-related deaths in patients with lung adenocarcinoma (LAD) is due to distant metastasis. Many reports have indicated that miRNA plays a key role in tumour metastasis. The expression of miR-197 is correlated with LADprogression, however, the mechanism of miR-197 is still unknown in the processing of LAD. A Boyden chamber migration/invasion assay was used for the metastatic function study in vitro. Real-time PCR andWestern blot assays were employed to analyse the
EMT
hallmark changes in both the mRNA and protein levels. 3'-UTR reporter luciferase assay was used to show that
HIPK2
is a directtarget of miR-197. miR-197 enhances LAD cell migration and invasion miR-197. The downregulation of miR-197 suppresses the
EMT
and migration ability.
HIPK2
is a direct functional target of miR-197 in LAD metastasis. In summary, miR-197 controls
EMT
and metastasis by directly silencing
HIPK2
. The findings suggest that interfering with the miR-197-dependent regulation of
HIPK2
could be a useful approach for the treatment of patients with late stage metastatic LAD.
...
PMID:MicroRNA-197 induces epithelial-mesenchymal transition and invasion through the downregulation of HIPK2 in lung adenocarcinoma. 2966 24